| Titre : | Do national medicinal drug policies and essential drug programs improve drug use ? a review of experiences in developing countries. (2001) |
| Auteurs : | Sauwakon RATANAWIJITRASIN ; Stephen-B SOUMERAI ; Krisantha WEERASURIYA |
| Type de document : | Article |
| Dans : | Social science and medicine (vol. 53, n° 7, 2001) |
| Pagination : | 831-844 |
| Langues: | Anglais |
| Mots-clés : | Médicament ; Politique santé ; Programme santé ; Utilisation ; Réglementation ; Evaluation ; Pays voie développement ; Médicament essentiel |
| Résumé : | [BDSP. Notice produite par INIST-CNRS BAR0xg3z. Diffusion soumise à autorisation]. Increasing concerns regarding access to and appropriateness of medicinal drug use have led many governments in developing countries to develop national policies and regulations intended to increase the affordability, supply, safety, and rational use of pharmaceuticals. However, little is known about the intended and unintended impacts of these social experiments on actual drug use. We conducted a critical review and synthesis of the international literature in an attempt to define the current state of knowledge regarding drug policy effects on drug use, and to extract from the evidence important lessons for future policy and research. Literature sources included the archives and computerized databases, articles published in medical and pharmacy journals, as well as published annotated bibliographies. The evaluated interventions included three broad categories : (1) multi-component national drug policies including essential drug programs ; (2) drug supply and cost-sharing programs ; and (3) regulatory measures. Most of these studies utilized weak research designs that evaluated programs solely on the basis of post-intervention measures. Only two studies measured pre-policy utilization, but did not include a control group. Thus, none of the results are conclusive, and the findings represent, at best, hypotheses for more rigorous studies of policy impacts. Some suggestive findings include an association between increases in the supply of essential drugs (combined with training) and more appropriate use of medications in primary care settings. In addition, preliminary data suggest some unintended effects of de-registration of drugs or upward reclassification of specific medicines. Similarly, loosening restrictions have sometimes been accompanied by increased dispensing of specific drugs by unqualified personnel. The available studies focused only on a few categories of national and regulatory policies. |
Service Documentation EHESP
Me connecter
PORTAIL DOCUMENTAIRE
École des hautes études en santé publique
Catalogue
Multi-bases
Accueil
Sélection de la langue
Adresse
Service Documentation EHESPBibliothèque Rennes Avenue du Professeur Léon Bernard – CS 74312 – 35043 Rennes Cedex Bibliothèque MSSH Paris 20 avenue George Sand - 93210 La Plaine Saint-Denis
France
Bibliothèque Rennes : 02 99 02 29 50 Bibliothèque MSSH Paris : 02 99 02 24 50
contact